Status:
UNKNOWN
Prehabilitation and Rehabilitation for Patients With Oesophageal Cancer
Lead Sponsor:
Gabriella Alexandersson von Döbeln
Conditions:
Esophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with oesophageal cancer selected for oncological and surgical treatment with curative intent are offered supervised physiotherapy and home-based training before and after surgery.
Detailed Description
Patients with loco-regional oesophageal cancer who will receive neoadjuvant chemotherapy or chemoradiotherapy followed by surgery and sometimes adjuvant chemotherapy are eligible to be enrolled in the...
Eligibility Criteria
Inclusion
- Histopathologically confirmed squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma in the oesophagus or cardia (Siewert I or II), cT1 N+ or cT2-4a any N, M0, according to the 8th version of the AJCC TNM classification.
- Assessed at a multidisciplinary conference to be suitable for curatively intended oncological and surgical treatment.
- Age \> 18 years.
- Performance status ECOG 0-2.
- Patient has provided written informed consent.
Exclusion
- Previous radiotherapy in the thorax (except for tangential field radiotherapy for breast cancer).
- Inability to understand written and spoken instructions and to comply with protocol requirements.
Key Trial Info
Start Date :
April 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04894149
Start Date
April 22 2021
End Date
May 1 2023
Last Update
May 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University hospital
Stockholm, Sweden